PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26156412-7	2016	RESULTS: Taking 100 mg CoQ10 supplement daily resulted in a significant decrease in liver aminotransferases (aspartate aminotransferase [AST] and gamma-glutamyl transpeptidase [GGT]), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha, and the grades of NAFLD in the CoQ10 group in comparison to the control group (p < 0.05).	coenzyme Q10	23-28	solute carrier family 17 member 5	Homo sapiens	109-135	
26156412-7	2016	RESULTS: Taking 100 mg CoQ10 supplement daily resulted in a significant decrease in liver aminotransferases (aspartate aminotransferase [AST] and gamma-glutamyl transpeptidase [GGT]), high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor alpha, and the grades of NAFLD in the CoQ10 group in comparison to the control group (p < 0.05).	coenzyme Q10	23-28	solute carrier family 17 member 5	Homo sapiens	137-140	
33080906-6	2020	Results: The administration of the association of silymarin, vitamin C, vitamin E, coenzyme Q10 and selenomethionine (Medronys epato ) was effective since it showed a significant reduction of the evaluated parameters of ALT, AST, ALP and GGT, a significant improvement of lipid parameters, evaluated as markers of liver function, and improvements of ultrasonographic results.	coenzyme Q10	83-95	solute carrier family 17 member 5	Homo sapiens	225-228